Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSCW) Revenue (2020 - 2025)

Historic Revenue for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to $493104.0.

  • Ensysce Biosciences' Revenue fell 8557.69% to $493104.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 150.56%. This contributed to the annual value of $5.2 million for FY2024, which is 13357.92% up from last year.
  • According to the latest figures from Q3 2025, Ensysce Biosciences' Revenue is $493104.0, which was down 8557.69% from $1.4 million recorded in Q2 2025.
  • Ensysce Biosciences' 5-year Revenue high stood at $3.4 million for Q3 2024, and its period low was $181797.0 during Q2 2024.
  • Its 5-year average for Revenue is $877865.6, with a median of $515032.0 in 2023.
  • Per our database at Business Quant, Ensysce Biosciences' Revenue skyrocketed by 68525.72% in 2024 and then crashed by 8557.69% in 2025.
  • Over the past 5 years, Ensysce Biosciences' Revenue (Quarter) stood at $1.6 million in 2021, then dropped by 12.34% to $1.4 million in 2022, then crashed by 64.07% to $515032.0 in 2023, then soared by 153.12% to $1.3 million in 2024, then crashed by 62.18% to $493104.0 in 2025.
  • Its Revenue stands at $493104.0 for Q3 2025, versus $1.4 million for Q2 2025 and $1.3 million for Q1 2025.